Catalyst Wire Dossier Catalyst Wire Dossier

Gastrografin

diatrizoate meglumine and diatrizoate sodium · Bracco S.p.A.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Gastrografin, covering 2008-01-28 to 2023-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Gastrografin for Treating Small Bowel Obstruction in Children [Phase 2, Phase 3]

See pricing